[
  {
    "ts": "2026-02-08T01:05:34+00:00",
    "headline": "Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting After New Valuation Updates",
    "summary": "West Pharmaceutical Services has seen its fair value estimate trimmed slightly, with the price target moving from about US$345.71 to US$338.57 per share as analysts refresh their models around growth and risk. The latest commentary links this shift to somewhat softer revenue growth assumptions and a marginally higher discount rate, which together pull the valuation estimate a bit lower, even as the core story remains under debate. Stay tuned to see how you can keep on top of these evolving...",
    "url": "https://finance.yahoo.com/news/why-narrative-around-west-pharmaceutical-010534323.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "657a9274-6d66-3e79-af9c-7358201b9b55",
      "content": {
        "id": "657a9274-6d66-3e79-af9c-7358201b9b55",
        "contentType": "STORY",
        "title": "Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting After New Valuation Updates",
        "description": "",
        "summary": "West Pharmaceutical Services has seen its fair value estimate trimmed slightly, with the price target moving from about US$345.71 to US$338.57 per share as analysts refresh their models around growth and risk. The latest commentary links this shift to somewhat softer revenue growth assumptions and a marginally higher discount rate, which together pull the valuation estimate a bit lower, even as the core story remains under debate. Stay tuned to see how you can keep on top of these evolving...",
        "pubDate": "2026-02-08T01:05:34Z",
        "displayTime": "2026-02-08T01:05:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4G9ppBeYPHN150Vf7ljszA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJ2VkF_7pHDs8.rNQqRscw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-narrative-around-west-pharmaceutical-010534323.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-narrative-around-west-pharmaceutical-010534323.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]